A Phase II Clinical Trial of Chiglitazar for NASH

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

January 2, 2024

Study Completion Date

January 2, 2024

Conditions
NASH
Interventions
DRUG

chiglitazar sodium tablets

the drugs will be given orally once a day

DRUG

Placebo

no active drug contained

Trial Locations (15)

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

Unknown

Beijing Youan Hospital, Capital Medical University, Beijing

Peking University People's Hospital, Beijing

The First Hospital of Lanzhou University, Lanzhou

Foshan First People's Hospital, Foshan

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

Henan Provincial People's Hospital, Zhengzhou

The First Affiliated Hospital of Anhui Medical University, Hefei

Nanjing Second Hospital, Nanjing

The First Hospital of Jilin University, Ch’ang-ch’un

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Shanghai Tongren Hospital, Shanghai

The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

Affiliated Hospital of Hangzhou Normal University, Hangzhou

First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

Sponsors
All Listed Sponsors
lead

Chipscreen Biosciences, Ltd.

INDUSTRY